DSIJ Mindshare

Flair Writing Industries is all set to launch an IPO as it filed a DRHP with SEBI. It aims to raise Rs. 450 crore, of which the fresh issue amounts to Rs. 330 crore, while the remaining Rs. 120 crore pertains to an offer for sale.

The company received World Health Organisation's final approval for anti-HIV drug Efavirenz. The stock hit upper circuit right from pre-opening trading session and was buzzing through the day.

Glenmark Pharma is said to have received zero observations from USFDA for its Baddi plant. The stock opened flat to negative, but bounced back 2.5 per cent in the first 1.5 hours and is currently trading up by 1 per cent at 12:54 hours. 

Road and Infrastructure developer Dilip Buildcon has been declared lowest bidder for a new EPC project Navnera Barrage (Dam) under phase 1/A.

Parag Milk Foods informed the bourses that the company has launched ‘Kesar dahi’ under Gowardhan brand. The launch would enable the company to enhance its curd portfolio, which is a low margin product.